Search This Blog

Thursday, November 19, 2026

Johnson & Johnson submits FDA application to expand CAPLYTA for bipolar 1

 

Johnson & Johnson submits FDA application to expand CAPLYTA for manic or mixed episodes associated with bipolar I disorder.

  • Johnson & Johnson names Houston’s Memorial Hermann-Texas Medical Center as first hospital for Ottava surgical robot, beginning early-access commercial rollout.

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.